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A study protocol is presented for the investigation of meditative movement (MM) as
a treatment for pulmonary dysfunction in flight attendants (FA) who were exposed to
second-hand cigarette smoke while flying before the smoking ban. The study will have
three parts, some of which will run concurrently. The first is a data gathering and screening phase, which will gather data on pulmonary and other aspects of the health of FA,
and will also serve to screen participants for the other phases. Second is an exercise
selection phase, in which a variety of MM exercises will be taught, over a 16-week
period, to a cohort of 20 FA. A subset of these exercises will be selected on the basis of
participant feedback on effectiveness and compliance. Third is a 52-week randomized
controlled trial to evaluate the effectiveness of a digitally delivered form of the previously
selected exercises on a group of 20 FA, as compared with an attention control group.
Outcome measures to be used in all three parts of the study include the 6-min walk
test as a primary measure, as well as a range of biomarkers, tests, and questionnaires
documenting hormonal, cardio-respiratory, autonomic, and affective state. This study is
registered at ClinicalTrials.gov. Identifier: NCT02612389.
Keywords: meditative movement, Qigong, flight attendants, second-hand cigarette smoke, pulmonary
dysfunction, COPD, autonomic nervous system, inflammation

BACKGROUND
COPD and Its Co-Morbidities in FA

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
worldwide; the primary cause of COPD is exposure to cigarette smoke. Those exposed to secondhand cigarette smoke (SHCS) are at increased risk for respiratory, cardiovascular, and other organ
system disease that are similar to those suffered by smokers (1). Many flight attendants (FA) who
flew before the ban on smoking in commercial aircraft, and who were thus exposed to SHS, have
abnormal pulmonary function consistent with mild COPD, despite not meeting the GOLD criteria
of reduced FEV1/FVC ratio (2). They also show increased rates of many of the co-morbidities associated with COPD, such as chronic bronchitis, cardiovascular disease, skin cancer, and depression
and anxiety (3). The co-morbidities of COPD exacerbate and are exacerbated by the COPD (4).
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Thus, consideration of the co-morbidities of COPD is an essential
aspect of its treatment (4). Significant co-morbidities include
cardiovascular disease (4); depression and anxiety (5); muscle
weakness, osteoporosis, skin and lung cancer, and diabetes (4);
as well as autonomic disturbance (6), systemic inflammation and
cachexia (4); frequent hypoxia, dyspnea, and disturbed breathing patterns (7); and disturbed posture and movement (8); see
Figure 1.

Meditative movement has been shown to be an effective
intervention for COPD (30, 32–36) and equivalent or superior
to conventional pulmonary rehabilitation in benefiting several
symptoms of COPD (37).
Meditative movement may also be of benefit in many
co-morbidities of COPD, such as heart disease risk factors (38,
39), hypertension (39, 40), depression and anxiety (26, 41), diabetes (42), osteoporosis (43), and muscle weakness (44), as well
as reduced immune function (45, 46), inflammation (47, 48),
and autonomic imbalance (49). Many of these beneficial effects
may happen via the influence of MM on the ANS (26, 50); see
Figure 3.

The Autonomic Nervous System in COPD

Autonomic dysfunction (AD) is known to be associated with
COPD and most of its co-morbidities (6, 9–15); see Figure 2.
Most of the diseases known to be co-morbidities of COPD may
be caused or exacerbated by AD; for instance, cardiovascular
disease (15, 16); hypoxia (17, 18); disturbed respiratory patterns
(7, 19, 20); disturbed posture and movement patterns (21, 22);
diabetes (17); immune function (4); airways restriction (6, 23);
and anxiety and depression (12).

Study Aims

To evaluate COPD-related health factors in FA exposed to SHCS
while flying, and to determine the effects of digitally delivered
MM training on these factors.
There are three sub-aims, relating to the three main aspects
of the study:

Meditative Movement

Qigong, a traditional Chinese health practice, has been used in
China for hundreds of years in treating those with respiratory
disease (24). Recently, a case has been made for a novel category
of exercise “meditative movement,” (MM) of which Qigong, Tai
Chi, and Hatha Yoga are examples (25). Significantly, MM is
hypothesized to act via its effect on the autonomic nervous system
(ANS) (26, 27), as well as on neuromuscular control (28, 29),
musculoskeletal condition (30), and mental state (31).

(1) To investigate the hypothesis that COPD-related pulmonary
and other symptoms in SHCS-exposed FA are part of a
syndrome of related disorders.
(2) To determine that MM practices are most suited to and effective for ameliorating pulmonary dysfunction and related
health problems in FA exposed to SHCS.
(3) To conduct a randomized controlled trial (RCT) to determine whether this specifically adapted MM training can be

FIGURE 1 | Reciprocal influences of core COPD pathology and the co-morbidities of COPD.
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FIGURE 2 | Relationships of autonomic dysfunction to the co-morbidities of COPD.

effectively delivered digitally, providing the benefits of MM
without face-to-face instruction being necessary.

Selection

To determine which of a variety of possible MM exercises are most
effective in improving specific outcome measures, most enjoyable, and most likely to be practiced in a cohort of FA exposed
to SHCS and having a degree of pulmonary dysfunction. This is
done by conducting a 16-week in-person MM training program
that is held in the Northeastern region of the US. Participants
provide extensive feedback on the exercises.

METHODS
Overall Structure of the Study

This study has three stages: Screening, Selection, and RCT.
Screening will continue throughout the study and will gather data
as well as serving to provide participants for the other Selection
and RCT stages. The RCT will follow the Selection stage. All
aspects of this study have been approved by the Dartmouth
IRB. Additionally, this study is registered at ClinicalTrials.gov
Identifier: NCT02612389. https://clinicaltrials.gov/ct2/show/
NCT02612389/

Rationale

Meditative movement offers an inexpensive intervention that
could benefit pulmonary symptoms and other related symptoms,
through its effect on the ANS, cardiovascular, and immune systems. However, there is a large body of possible MM exercises,
and there has been no investigation of the relative effectiveness,
acceptability, and compliance among FA for the many MM
exercises that are traditionally recommended for COPD-related
symptoms. To our knowledge, no other study has attempted to
evaluate a wide range of MM practices to determine which are
most appropriate for the population being studied.

Screening

To screen a cohort of FA exposed to SHCS for a range of biomarkers and symptoms to determine whether symptom clusters exist
that suggest a syndromal entity.

Rationale

Flight attendants exposed to SHCS have been observed to display
a wide range of respiratory, functional, inflammatory, autonomic,
cardiovascular, affective, and other symptoms. The possible
relationship between these symptoms has not previously been
explored. We hypothesize that these symptoms may be correlated
and form a syndromal entity.

Frontiers in Psychiatry | www.frontiersin.org

Randomized Controlled Trial

To develop a DVD or other digital form for delivering the selected
exercises that have proven to most appropriate for this population, and to test by RCT the effectiveness of this digital format
in improving specified outcome measures in a group of FA with
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FIGURE 3 | Hypothesized pathways of direct and indirect influence of MM on co-morbidities of COPD.

pulmonary dysfunction and exposed to SHCS, as compared to
a matched attention control group who will watch educational
digital material of similar length.

the Harvard Flight Attendant Health Study. Social media support
is also provided by Department of Health Behavior at the Roswell
Park Cancer Institute in Buffalo, NY, USA.

Rationale

Randomization and Blinding

Selecting appropriate exercises and providing face-to-face
instruction in MM offers significant difficulty due to the lack of
trained teachers in most areas of the country and the practical
demands of attending classes. A digitally delivered format would
make this intervention much more accessible, and an RCT will
evaluate the effectiveness of this intervention.

The Screening and Selection stages of this study do not use a
control group; blinding and randomization are, therefore, not
necessary. In the RCT, participants will be stratified by gender,
age, and severity of pulmonary dysfunction and randomized to
an intervention groups and an attention control, using the covariate adaptive randomization method (51). This method accommodates recruitment and testing over an extended period of time.
Full blinding of participants to intervention is not possible under
these circumstances; however, all scoring of tests will be done by
assistants blinded as to participant group.

Participants
Recruitment

Flight attendants were recruited from the Northeastern region
and other areas of the US for the Selection stage; the Screening and
RCT stages will involve recruitment throughout the continental
US in locations convenient to data collection points. Primary
outreach is through existing FA organizations and networks,
social media, and FA publications, as well as in conjunction with

Frontiers in Psychiatry | www.frontiersin.org

Inclusion Criteria

The Screening stage of the study acts both to collect participant
baseline data and to determine eligibility for the Selection and
RCT stages.
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All participants must be current or former non-smoker FAs
employed by a US carrier for at least 5 years while smoking was
permitted in the aircraft cabin. They must have a score of above 5
on the COPD assessment test (CATest); this will eliminate those
with no detectable pulmonary issues. A score of 5 is a low score,
indicating minimal level of pulmonary dysfunction.
Many FA exposed to SHCS have detectable pulmonary abnormalities despite not meeting Gold criteria for mild COPD (2); we
wish to include this population, since they are likely at risk for
the future development of COPD or its co-morbidities. We will
eliminate any participants not meeting at least one of the following spirometric criteria: ratio of forced expiratory volume in 1 s
to forced vital capacity (FEV1/FVC) < 0.70; OR forced expiratory
flow (FEF) at 25–75%, volume <80% of predicted normal; OR FEF
at 50%, volume <80% of predicted normal; OR FEF at 75%, volume
<80% of predicted normal. We will follow procedures as described
by Arjomandi et al. (2) for determining normal FEF values.
Participants must be lifetime non-smokers, defined as having smoked <100 cigarettes in their lifetime. They must have
a device on which to listen to audio or watch video instruction
and be willing to do so; for the RCT portion of the study, capacity to watch online or DVD videos is required. Those who are
pregnant, or who plan to become pregnant during the study,
are excluded. Patients with cognitive impairment, severe emotional problems, or who are unable physically to perform the
exercises are excluded. Participants will be asked not to modify
their lifestyle significantly during the study period apart from
the practice required by the study. Participants must all sign
informed consent forms.

ask questions and make comments on the exercises; all questions
and comments are recorded in writing at the time. Individual
attention is given to the needs of each participant, and written
and audio explanations are also available to participants online.
(Please see the Supplementary Material for the description of
exercises from which we draw.)
The RCT stage of the study will involve the design of a digitally
delivered intervention based on the exercises determined in the
Selection stage to be most helpful. The intervention may be
delivered on a DVD or through a web site. The goal will be to
simulate as closely as possible the experience of attending a class
through the development of innovative methods, such as computer animation, branching path selection, and user-controlled
sequencing. Participants in the RCT will also have access to audio
and written materials. Attention control subjects in the RCT will
receive equivalent digitally delivered health education materials.

Safety Considerations

Very few studies of MM have reported significant risks (52) and
we do not anticipate any ill effects. Nevertheless, participants
are instructed to discontinue the exercise immediately if they
experience any of the following: dizziness, rapid or irregular
heart-beat, sudden or excessive dyspnea, chest pain, significant
pain anywhere in the body, and headache. In addition, during
the classes we carefully monitor the participants for signs of
distress, including facial paleness or redness, rapid breathing,
sweating, or jerky movement. Any data gathered that suggest
possible need for medical attention are drawn to the attention
of the participants.

Outcomes

Sample Size

The Screening stage of this study has no limit on number of
participants. For the Selection and RCT stages of the study, we
determined that, based on a predicted difference of 46 m in the
6-min walk test (6MWT) and an assessment of previous similar
studies of MM for COPD, this study required a sample size of
20 participants in each group to achieve a statistical power of
80% at a significance level of 5%. To compensate for anticipated
dropout, we recruited a total of 27 participants into the Selection
group. On the basis of our experience of a high dropout and
non-compliance rate in the Selection stage (~40%), we intend to
recruit 120 participants for the RCT, 60 for each group.

These are the outcome measures to be used in the Screening stage
of the study as well as to evaluate the effects of the MM practices
in the Selection and RCT stages. The broad range of outcome
measures will allow us to examine correlations between a wide
range of variables representing a number of different physiological and psychological systems that may be involved in COPD and
its co-morbid conditions.

Primary Outcome Measures

Six-minute walk test
Change in high sensitivity C-reactive protein (hs-CRP)

Interventions

Secondary Outcome Measures

The Screening stage of the study involves no intervention. In the
Selection stage, the MM intervention is given in person in small
groups (between 3 and 7), in 3-h classes, spaced 2–4 weeks apart,
in locations convenient to the participants, for a total of 18 h of
contact time over 4 months. Participant feedback will be solicited
as to the subjective effectiveness, enjoyability, and likelihood of
regular practice of each specific exercise.
The MM classes will be taught by one of the authors, Peter
Payne, a Qigong teacher with over 40 years experience. In the
classes, rather than teaching rote movements, the purpose and
philosophy behind each exercise is explained. Suggestions are
made as to how to set up a regular practice and how to integrate
the exercises into everyday life. The participants are encouraged to

Frontiers in Psychiatry | www.frontiersin.org

Blood pressure (BP) (pre- and post-6MWT),
Heart rate (HR) (pre- and post-6MWT),
Blood oxygen saturation,
Spirometry FVC, FEV1, FEF 25–75,
Compass 31 (Autonomic function self-report),
Zung Depression Inventory,
Zung Anxiety Inventory,
COPD Assessment Test (CATest),
FA Health Questionnaire,
Multidimensional Assessment of Interoceptive Awareness
(MAIA),
Borg Dyspnea Scale,
Heart Rate Variability (HRV),
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technician using standard clinical instruments. Cardiac R-R
intervals are recorded over the entire testing period (about 1½ h)
using a commercially available system, the Holter myPatch 24-h
single channel AMS3000 from DMS-Services, Los Angeles, CA,
USA. This is a non-intrusive device, using two electrodes. Due to
problems with availability, this measure was not included with
some participants during the Selection stage of the study only.
Blood oxygen saturation is also measured, using a Choicemmed
Oxywatch Fingertip Pulse Oximeter.

2 Ewing tests,
Urine analysis (melatonin and cortisol),
Saliva analysis (diurnal cortisol), and
Blood (fingerprick) analysis.
All tests are administered by trained researchers. Blood, urine,
and saliva analysis provided by ZRT Laboratory, Beaverton,
OR, USA.

Outcome Measurement Details
General Health
Flight Attendant Health Questionnaire

Autonomic Condition
Heart rate Variability

This was developed by Dr. Eileen McNeely at the Harvard School
of Public Health. Its use provides us with a health and FA-related
occupational history and enables us to compare our study results
with those of Dr. McNeely.

Subjects are asked to sit quietly for 10 min. In post-analysis, the
HR data collected during these periods is used to calculate HRV.
HRV data will be analyzed using software provided by the manufacturer: CardioScan II, version 12.4.0054a, from DMS Software,
Los Angeles, CA, USA. Time domain (SDNN, RMSSD) and
frequency domain [power spectral density (PSD)] analysis methods will be used. Dr. Phyllis Stein, Director of the Washington
University School of Medicine HRV Lab, will serve as a consultant on HRV analysis and interpretation. HRV measurements are
only available for a subset of participants in the Selection stage
due to delayed availability of HR monitors; monitors will be fully
available during the RCT stage.

Functional Ability

Exercise endurance and tolerance is evaluated by the 6MWT followed by the Borg Dyspnea inventory. This is used as our principal
outcome measure since it is a well-recognized measure of overall
functional ability. The walk is conducted on an indoor level surface free of obstructions. Research assistants are on hand to assist
participants with any difficulties. Maximum distance walked in
6 min is recorded (53–55). The difference in scoring from baseline
to the end of study is calculated for each participant. The Borg
Dyspnea Inventory, a well-established instrument for measuring
respiratory distress, is administered following the 6MWT. The
6MWT is subject to variation due to motivation; the addition of
the Borg instrument increases the reliability of the test.

Ewing Tests

The Ewing tests evaluate cardiac autonomic function by measuring the response of HR or blood pressure to a physical challenge.
We will administer two of the battery of five Ewing Tests: deep
breathing heart rate challenge (DBHR) and lying to standing
blood pressure challenge (LSBP). DBHR has been determined to
be the most significant of the Ewing tests, carrying 80% of the
significance. To measure this, participants will be asked to breathe
deeply for three 1-min periods at a rate of six times a minute;
post-analysis using recorded R-R intervals will enable evaluation
of HR response to challenge, which is a measure of the integrity of
the sympathetic branch of cardiac autonomic control. To measure
LSBP, the systolic blood pressure change from supine to standing
is measured. This gives an indication of cardiac parasympathetic
function. Comparing the results from HR, BP, HRV, DBHR,
and LSBP will allow a more accurate evaluation of the cardio-
respiratory autonomic system than any one of them taken alone.
Full Ewing test results are only available for a subset of participants
due to problems with availability of the heart monitors.

Respiratory Health
The COPD Assessment Test

The CATest is used as an initial recruitment screening as well as
an outcome measure. Volunteers must score above 5 for inclusion in the study. Its main purpose is to eliminate those with no
appreciable respiratory dysfunction.

Spirometry
FEV1/FVC and Flow/Volume Curves

Forced expiratory volume in 1 s to forced vital capacity and Flow/
Volume Curves are used as part of the inclusion criteria (see
above under inclusion criteria), and to determine the degree of
pulmonary dysfunction. We use specific validated spirometric
cut points (56). We record FEV1/FVC ratio and Flow/Volume
Curves using the EasyOne Plus Frontline spirometry system.
FEV1/FVC is a standard measurement used to determine the
GOLD grade of COPD. The Flow/Volume Curves indicate the
degree of pulmonary dysfunction; participants with no detectable
pulmonary dysfunction are excluded from the study. The differences in scoring from baseline to specific intervals are calculated
for each participant.

COMPASS 31

In addition, we administer the COMPASS 31, a questionnaire for
detecting dysfunction in many aspects of the ANS.

Affective State
Zung Anxiety and Depression Inventories

These evaluate the degree of affective disturbance. They are both
well validated and widely used instruments. Since depression
and anxiety are significant co-morbidities of COPD, and since
we speculate that MM intervention will have an impact on them,
the Zung inventories are relevant.

Cardiovascular Measures
Blood Pressure and Heart Rate

Blood pressure and HR are measured at the beginning of each
testing period and before and after the 6MWT by a trained

Frontiers in Psychiatry | www.frontiersin.org
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tests at baseline. An intent-to-treat analysis will be carried out
where missing data will be handled by multiple imputation
approach, and linear regression models will be used to compare
the intervention group with the control group in terms of the
primary outcomes.

Interoceptive Awareness
The Multidimensional Assessment of Interoceptive Awareness
(MAIA)

The Multidimensional Assessment of Interoceptive Awareness
(MAIA) is a questionnaire that evaluates the degree of a person’s
awareness of interoceptive cues, as well as his or her degree of
comfort with these cues. We believe this is relevant to a person’s
ability to benefit from the MM intervention.

Stepwise Methods

Stepwise methods are detailed in Figure 4.

Anticipated Results

Biomarkers

In the Selection and the RCT stages of this research, it is
anticipated that subjects in the study will increase endurance as
demonstrated by an increase in the 6MWT by margins that meet
or exceed statistical significance. A general marker of inflammation, hs-CRP, is expected to decrease significantly. Consistent
with evidence that MM may benefit the ANS, we expect to see
a decrease in blood pressure. With the larger number of subjects
in the RCT stage of the study, secondary measures are expected
to provide data suggesting or discounting relationships between
ANS function, mood, pulmonary, and immune system functions.

Biomarkers include urine, saliva, and blood analysis.

Blood Analysis

Capillary blood drops will be taken from the finger following fingerprick with a lancet, and deposited onto a blood spot card used
specifically for dried blood spot (DBS) collections. Blood spots are
dried on the filter card for at least 2 h before closing the cover and
then further dried overnight at room temperature before storing
the cards for shipment to ZRT Laboratory. Six-millimeter disks of
blood spots are punched into 96-well plates and the blood extracted
with buffers. Extracts are assayed for C-reactive protein (CRP), a
marker of inflammation, as well as HbA1c (a marker of metabolic
function), thyroid stimulating hormone, and Vitamin D.

Pitfalls, Artifacts, and Troubleshooting

A potential pitfall in this study is the difficulty in recruiting and
retaining subjects. Our extensive network of contacts among
FA will facilitate this process, as will our outreach through
FA-connected social media. The recruitment process can be
extended in time to assure adequate numbers. In addition, the
researchers are prepared to travel to locations throughout the
country as necessary.
Retention of subjects in the second and third stages is another
concern. It is anticipated that retention will not exceed the 40%
of the Selection stage of the study, as the exercises to be taught
are simple and enjoyable. However we are allowing for up to 60%
drop-out rate. Should dropout be more than anticipated, we will
need to recruit more subjects, which should prove possible. We
have maintained good communication with all subjects.
In the Selection stage of the study, any difficulties participants
have had with the training, including safety-related concerns,
were explored as a source of information concerning appropriate
selection of exercises; this was one of the aims of this portion of
the study.
The smoking status of study participants is queried during the
recruitment and further during testing for each stage of this study.
However, additional details of a smoking history have, in a few
cases, emerged when other data had already been collected on
these subjects. Outcomes from these subjects will be sequestered
and reported separately from those who smoked less than 100
cigarettes in a lifetime.
Due to limited availability of equipment, the wearable ECGs
were not used in the majority of pre-testing in the Selection stage.
Changes in HRV are, therefore, not documented. However, other
measures of cardiovascular autonomic function were made,
including HR, BP, and changes in these measures in response to
challenge. These will provide some information about possible
autonomic changes.
In the Selection stage, we do not use a control group. Since
the purpose of this portion is to determine that MM exercises

Urine Steroid Hormone and Element Testing

Participants will be asked to provide first morning and then a bedtime urine samples: these are collected onto an absorbent paper
strip and dried. They will be instructed in correct procedures for
this. The sample will later be analyzed at ZRT Lab to determine
by LC-MS/MS levels of urinary free cortisol, free cortisone, and
melatonin, and by ICP-MS levels of iodine, bromine, selenium,
arsenic, cadmium, and mercury (all normalized to creatinine).

Salivary Steroid Hormone Testing

Participants are instructed to provide four saliva samples over the
course of a day. These samples will be stored frozen and batchshipped to ZRT Laboratory and analyzed to determine diurnal
cortisol levels as well as first morning estradiol, progesterone, testosterone, and dehydroepiandrosterone (DHEA) by LC-MS/MS.
Dried blood spots, dried urine (DU), and saliva samples are
mailed to the researchers and stored at −70°C until they can be
shipped in bulk to ZRT Labs for testing.
This extensive range of biomarkers will allow us to examine
correlations between levels of function of a wide range of physiological systems and pulmonary dysfunction.
During the Selection and RCT stages of the study, feedback
will be gathered from participants through written logs, and a
questionnaire on Survey Monkey. Copies of the forms for the
written logs and the Survey Monkey questionnaire are available
as Supplementary Material.

Statistical Methods

Descriptive statistics, including mean, SD, and frequency, will
be used to describe and summarize baseline data. We will also
compare distributions between intervention and control groups
in the RCT stage using Wilcoxon rank-sum tests and chi-square

Frontiers in Psychiatry | www.frontiersin.org
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FIGURE 4 | Proposed timeline for the study.
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are most effective and best tolerated, use of a control group would
not be appropriate. This diminishes the power of results from
the pre-and post-intervention tests in this portion as it will not
be possible to determine with certainty whether results are due
to attention, seasonal or other factors. However, the final RCT
stage of the study, using an attention/health education control
group, will provide a well-controlled validation of the effects of
the selected MM exercises. It is, however, possible that positive
results from the testing in the Selection stage, followed by negative results from the RCT stage, would reflect the ineffectiveness
of digital delivery rather than the ineffectiveness of the intervention. In this case, an RCT testing in-person delivery would be
indicated.
The 6MWT is known to be influenced by motivation. The use
of the Borg Dyspnea Inventory is used as a control on this, as it
indexes amount of effort, and every precaution has been taken
by the researchers to standardize the administration of the test.
Nonetheless, in the Selection stage, subjects may be more highly
motivated in the post-test situation, and this could skew results.
As mentioned above, the use of a control group in the RCT stage
will provide a check on these results.
In the RCT stage, compliance is expected to be an issue. We
plan to be in contact by email, phone, and digital questionnaire
with all subjects on a weekly basis. We will follow up quickly
any lapses in communication or reporting of difficulties, so as to
minimize this issue. Such difficulties arising in this stage will also
provide further information for future refinement of the delivery
method and the selection of exercises.

Previous trials of the effects of MM have relied on a
preselected set of exercises, in some cases chosen for their
traditional relevance to the condition being treated (57) but in
most cases a traditional general set (30, 32–36). Our study is
the first to involve a test period in which a wide range of MM
exercises is evaluated for a specific population. We have already
observed that participants have trouble setting aside time for
regular practice. Our approach to MM includes a number of
practices that can be integrated with the activities of daily life
(rather than having to be practiced at a certain time), and we
have found that this form of practice is more acceptable to this
group of FA.
We experienced an unexpected level of dropout during the
Selection stage of the study. Given that the average age of participants is 69, this should have been anticipated. We have found
that the provision of exercises that can be integrated into daily
life, such as simple standing, sitting, walking, and breathing
practices, increases compliance and appears to reduce dropout.
We believe that the emphasis on this kind of practice can make
Asian practices more accessible and appealing to Westerners with
their busy lifestyles.
Our study explores the possibility of administering an MM
intervention by digital means. To our knowledge, no other study
of MM has tested this possibility. Information gained from this
aspect of the study may provide information about the most
effective ways of conveying MM training digitally, as well as
validating the effectiveness of MM for COPD-related pulmonary
dysfunction. Should our principal hypothesis be supported,
it would not only open the possibility of a safe, cost-effective
intervention for those with pulmonary dysfunction, but also
support the further exploration of digitally delivered MM for
a wide range of conditions, especially those with a significant
autonomic component.

DISCUSSION
We believe that the ANS may be a link between the various
co-morbidities of COPD.
We speculate that COPD-related pulmonary and other
co-morbid conditions appearing in FA exposed to SHCS may be
part of a syndrome of interacting conditions related to disturbed
autonomic function. The Screening stage of this study will provide data to test this speculation.
In addition to our primary outcome measures, we are
gathering a wide range of data, including hormonal biomarkers, affective, and autonomic measures. This may allow for the
formulation of hypotheses for future testing concerning the
mechanisms of action of MM on pulmonary dysfunction and
other health conditions. In preliminary data, we are seeing patterns of subclinical morbidities that may provide an improved
picture of the health care needs of this unique group of workers. It, however, remains to be seen whether these patterns are
simply age related or unique to this group and their exposure
to SHCS.
Since MM has been shown to have beneficial effects on many
of the co-morbid conditions of COPD, possibly by way of its regulating effect on autonomic functioning, this suggests that a single
approach (MM) might target not only COPD-related respiratory
symptoms but also many other COPD-related conditions. Future
studies could determine whether MM could slow the progression
of pre-COPD conditions to clinical COPD.
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Trial Status

Recruitment for the Screening and evaluation portion of the study
began in August 2014 and will continue for the duration of the
study, until mid 2017. Comprehensive data have been gathered
on more than 60 participants to date, and preliminary analysis
has begun.
Recruitment for the MM exercise selection portion of the study
began in October 2014 and will continue through October 2015.
While 27 participants have been recruited so far into the Selection
stage, there is concern for assuring that a statistically significant
number will complete this stage of the study. No adverse events
have been reported. Post-intervention testing began in July 20
2015, and is on going.
Preparations for the development of a digitally deliverable
MM intervention are presently underway, involving developing
video footage and planning. Recruitment for the RCT portion of
the study began in October 2015.
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APPENDIX
ACRONYMS
6MWT
ANS
BP
COPD
CRP
DBHR
DVD
EAC
FA
FAMRI
FEF
FEV1
FVC
GOLD
HR
HRV

Six-minute walk test
Autonomic nervous system
Blood pressure
Chronic obstructive pulmonary disease
C-reactive protein
Deep breathing heart rate
Digital video disk
Education activity control
Flight attendants
Flight attendant medical research institute
Forced expiratory flow
Forced expiratory volume one
Forced vital capacity
Global initiative on obstructive lung disease
Heart rate
Heart rate variability

A standard test for assessing functional ability, the distance walked in 6 min
Portion of the nervous system controlling those physiological functions outside normal voluntary control
Chronic disease involving obstruction of the small airways
Biomarker of inflammation
One of the battery of 5 Ewing tests for cardiac autonomic dysfunction; the most significant of the 5
Standard vehicle for presenting video
A control group engaging in educational activity, in this case watching educational videos
The foremost organization promoting research into medical problems affecting flight attendants
Spirometric measurement, flow of air during forced exhalation
A measure of lung function: the maximum volume of air breathed out in a forcible exhalation in 1 s
A measure of lung function: the total volume of air breathed out in a complete forcible exhalation
A research and information group that is the principal global authority on the nature and treatment of COPD

Degree of variability over time (especially in synchrony with the breathing) of the R-R, or beat-to-beat, heart
rate; since this variation of heart rate is under control of the parasympathetic nervous system, HRV offers a
way of evaluating this aspect of ANS function
LSBP
Lying standing blood pressure
A Ewing test of the blood pressure response to going from lying to standing
MAIA
Multidimensional assessment of interoceptive A questionnaire designed to evaluate several dimensions of interoceptive awareness
awareness
MM
Meditative movement
A newly identified form of exercise characterized by a meditative state of mind, deep relaxation, movement,
and attention to the breathing. Qigong and Yoga are the best known examples
NHANES National health and nutrition examination
survey
PI
Principal investigator
PSD
Power spectrum density
A measure of frequency distribution used to evaluate HRV
QOL
Quality of life
A general measure of the quality of a patients daily life
RCT
Randomized controlled trial
The premier form of research study in which participants are randomly assigned to control or intervention
group for the purpose of objective assessment of an intervention
RMSSD Root mean square standard deviation
A statistical method used in this study for the analysis of HRV data
SDNN
Standard deviation
A statistical method used in this study for the analysis of HRV data
SHCS
Second-hand cigarette smoke
Cigarette smoke inhaled by someone other than the smoker; ambient smoke not inhaled directly through
the cigarette
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